Vaccinia DNA topoisomerase forms a covalent DNA-(3-phosphotyrosyl)-enzyme intermediate at a specific target site 5-C ؉5 C ؉4 C ؉3 T ؉2 T ؉1 p2N ؊1 in duplex DNA. Here we study the effects of base modifications on the rate and extent of single-turnover DNA transesterification. Chiral trans opened C-10 R and S adducts of benzo[a]pyrene (BP) 7,8-diol 9,10-epoxide were introduced at single N 6 -deoxyadenosine (dA) positions within the 3-sequence of the nonscissile DNA strand. The R and S BPdA adducts intercalate from the major groove on the 5 and 3 sides of the modified base, respectively, and perturb local base stacking. We found that R and S BPdA modifications at ؉1A reduced the transesterification rate by a factor of 700 -1000 without affecting the yield of the covalent topoisomerase-DNA complex. BPdA modifications at ؉2A reduced the extent of transesterification and elicited rate decrements of 200-and 7000-fold for the S and R diastereomers, respectively. In contrast, BPdA adducts at the ؊2 position had no effect on the extent of the reaction and relatively little impact on the rate of cleavage. A more subtle probe of major groove contacts entailed substituting each of the purines of the nonscissile strand with its 8-oxo analog. The ؉3 oxoG modification slowed transesterification 35-fold, whereas other 8-oxo modifications were benign. 8-Oxo substitutions at the ؊1 position in the scissile strand slowed single-turnover cleavage by a factor of six but had an even greater slowing effect on religation, which resulted in an increase in the cleavage equilibrium constant. 2-Aminopurine at positions ؉3, ؉4, or ؉5 in the nonscissile strand had no effect on transesterification per se but had synergistic effects when combined with 8-oxoA at position ؊1 in the scissile strand. These findings illuminate the functional interface of vaccinia topoisomerase with the DNA major groove.Poxvirus DNA topoisomerase is an attractive target for drug therapy of smallpox in light of its unique DNA recognition specificity, compact structure, and distinctive pharmacological sensitivities compared with human topoisomerase I (1-6). Poxvirus topoisomerase, exemplified by the 314-amino acid vaccinia virus enzyme, is a prototype of the type IB DNA topoisomerase family (7-9). Type IB enzymes cleave and rejoin one strand of the DNA duplex through a transient DNA-(3Ј-phosphotyrosyl)-enzyme intermediate.Poxvirus topoisomerases bind and cleave duplex DNA at a pentapyrimidine target sequence, 5Ј-(T/C)CCTTp2 (3). The T2 nucleotide (defined as the ϩ1 nucleotide) is linked to Tyr-274 of the vaccinia enzyme. Four conserved amino acid side chains found in all type IB topoisomerases (Arg-130, Lys-167, Arg-223, and His-265 in the vaccinia enzyme) are responsible for catalyzing the attack by tyrosine on the scissile phosphodiester to form the covalent intermediate (10 -12). The topoisomerase binds to DNA as a C-shaped protein clamp formed by an 80-amino acid N-terminal domain that contacts the DNA major groove and a 234-amino acid C-terminal catalytic domain ...